Jianyang Ao

Shanghai, 200120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Phosphoglucomutase 5 suppresses gallbladder cancer progression by inhibiting lactate-driven STAT3 signaling.

Phosphoglucomutase 5 suppresses gallbladder cancer progression by inhibiting lactate-driven STAT3 signaling.

Journal: Translational oncology

Published: November 12, 2025

Integrative computational simulations and functional assays decode allosteric dysregulation in a pathogenic SIRT6 variant.

Integrative computational simulations and functional assays decode allosteric dysregulation in a pathogenic SIRT6 variant.

Journal: International journal of biological macromolecules

Published: November 06, 2025

Molecular glues as GPCR modulators: unveiling three distinct mechanistic pathways for signal regulation.

Molecular glues as GPCR modulators: unveiling three distinct mechanistic pathways for signal regulation.

Journal: Drug discovery today

Published: July 21, 2025

Right-side versus left-side hemihepatectomy for the treatment of Bismuth type IV perihilar cholangiocarcinoma: a comparative study.

Right-side versus left-side hemihepatectomy for the treatment of Bismuth type IV perihilar cholangiocarcinoma: a comparative study.

Journal: Frontiers in oncology

Published: July 10, 2025

Decreasing the aggregation of photosensitizers to facilitate energy transfer for improved photodynamic therapy.

Decreasing the aggregation of photosensitizers to facilitate energy transfer for improved photodynamic therapy.

Journal: Nanoscale

Published: January 28, 2025

Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies.

Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies.

Journal: Frontiers in immunology

Published: January 12, 2025

Genomic and transcriptomic characteristics of 12 novel primary cell lines derived from three patients with cholangiocarcinoma.

Genomic and transcriptomic characteristics of 12 novel primary cell lines derived from three patients with cholangiocarcinoma.

Journal: Genomics

Published: July 06, 2023

Surgical treatment of hilar cholangiocarcinoma: retrospective analysis.

Surgical treatment of hilar cholangiocarcinoma: retrospective analysis.

Journal: BJS open

Published: August 19, 2022

Development and Evaluation of Nomograms to Predict the Cancer-Specific Mortality and Overall Mortality of Patients with Hepatocellular Carcinoma.

Development and Evaluation of Nomograms to Predict the Cancer-Specific Mortality and Overall Mortality of Patients with Hepatocellular Carcinoma.

Journal: BioMed research international

Published: May 03, 2020

Screening and verification of long noncoding RNA promoter methylation sites in hepatocellular carcinoma.

Screening and verification of long noncoding RNA promoter methylation sites in hepatocellular carcinoma.

Journal: Cancer cell international

Published: April 04, 2020

A novel molecular-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.

A novel molecular-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.

Journal: Aging

Published: October 04, 2019

Screening and verification of microRNA promoter methylation sites in hepatocellular carcinoma.

Screening and verification of microRNA promoter methylation sites in hepatocellular carcinoma.

Journal: Journal of cellular biochemistry

Published: August 20, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026